Kasiani C Myers1, Audrey Anna Bolyard2, Barbara Otto3, Trisha E Wong4, Amanda T Jones3, Richard E Harris1, Stella M Davies1, David C Dale3, Akiko Shimamura5. 1. Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. 2. Department of Medicine, University of Washington, The Severe Chronic Neutropenia International Registry, Seattle, WA. 3. Department of Medicine, University of Washington, Seattle, WA. 4. Puget Sound Blood Center, Seattle, WA; Department of Pediatrics, University of Washington, Seattle, WA; Seattle Children's Hospital, Seattle, WA. 5. Department of Pediatrics, University of Washington, Seattle, WA; Seattle Children's Hospital, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA. Electronic address: ashimamu@fhcrc.org.
Abstract
OBJECTIVES: To investigate the range of clinical presentations for Shwachman-Diamond syndrome (SDS) with the long-term goal of improving diagnosis. STUDY DESIGN: We reviewed the North American Shwachman-Diamond Syndrome Registry. Genetic reports of biallelic Shwachman-Bodian-Diamond syndrome mutations confirming the diagnosis of SDS were available for 37 patients. RESULTS: Neutropenia was the most common hematologic abnormality at presentation (30/37, 81%); however, only 51% (19/37) of patients presented with the classic combination of neutropenia and steatorrhea. Absence of pancreatic lipomatosis on ultrasound or computed tomography scan, normal fecal elastase levels, and normal skeletal survey do not rule out the diagnosis of SDS. SDS was diagnosed in 2 asymptomatic siblings of SDS probands. Twenty-four of 37 patients (65%) had congenital anomalies. CONCLUSION: Our cohort reveals a broad range of clinical presentation for SDS. Clues to the underlying diagnosis of SDS included cytopenias with a hypocellular marrow, congenital anomalies, family history, and myelodysplasia with clonal abnormalities frequently found in SDS. Reliance on classic clinical criteria for SDS would miss or delay diagnosis of a significant subset of patients with SDS.
OBJECTIVES: To investigate the range of clinical presentations for Shwachman-Diamond syndrome (SDS) with the long-term goal of improving diagnosis. STUDY DESIGN: We reviewed the North American Shwachman-Diamond Syndrome Registry. Genetic reports of biallelic Shwachman-Bodian-Diamond syndrome mutations confirming the diagnosis of SDS were available for 37 patients. RESULTS:Neutropenia was the most common hematologic abnormality at presentation (30/37, 81%); however, only 51% (19/37) of patients presented with the classic combination of neutropenia and steatorrhea. Absence of pancreatic lipomatosis on ultrasound or computed tomography scan, normal fecal elastase levels, and normal skeletal survey do not rule out the diagnosis of SDS. SDS was diagnosed in 2 asymptomatic siblings of SDS probands. Twenty-four of 37 patients (65%) had congenital anomalies. CONCLUSION: Our cohort reveals a broad range of clinical presentation for SDS. Clues to the underlying diagnosis of SDS included cytopenias with a hypocellular marrow, congenital anomalies, family history, and myelodysplasia with clonal abnormalities frequently found in SDS. Reliance on classic clinical criteria for SDS would miss or delay diagnosis of a significant subset of patients with SDS.
Authors: Robert Rothbaum; Jean Perrault; Adrianna Vlachos; Marco Cipolli; Blanche P Alter; Susan Burroughs; Peter Durie; M Tarek Elghetany; Richard Grand; Van Hubbard; Johanna Rommens; Thomas Rossi Journal: J Pediatr Date: 2002-08 Impact factor: 4.406
Authors: Yigal Dror; Jean Donadieu; Jutta Koglmeier; John Dodge; Sanna Toiviainen-Salo; Outi Makitie; Elizabeth Kerr; Cornelia Zeidler; Akiko Shimamura; Neil Shah; Marco Cipolli; Taco Kuijpers; Peter Durie; Johanna Rommens; Liesbeth Siderius; Johnson M Liu Journal: Ann N Y Acad Sci Date: 2011-12 Impact factor: 5.691
Authors: D Bhatla; S M Davies; S Shenoy; R E Harris; M Crockett; L Shoultz; T Smolarek; J Bleesing; M Hansen; S Jodele; M Jordan; A H Filipovich; P A Mehta Journal: Bone Marrow Transplant Date: 2008-05-26 Impact factor: 5.483
Authors: Andrew J Finch; Christine Hilcenko; Nicolas Basse; Lesley F Drynan; Beatriz Goyenechea; Tobias F Menne; Africa González Fernández; Paul Simpson; Clive S D'Santos; Mark J Arends; Jean Donadieu; Christine Bellanné-Chantelot; Michael Costanzo; Charles Boone; Andrew N McKenzie; Stefan M V Freund; Alan J Warren Journal: Genes Dev Date: 2011-05-01 Impact factor: 11.361
Authors: Tobias F Menne; Beatriz Goyenechea; Nuria Sánchez-Puig; Chi C Wong; Louise M Tonkin; Philip J Ancliff; Renée L Brost; Michael Costanzo; Charles Boone; Alan J Warren Journal: Nat Genet Date: 2007-03-11 Impact factor: 38.330
Authors: Kasiani C Myers; Elissa Furutani; Edie Weller; Bradford Siegele; Ashley Galvin; Valerie Arsenault; Blanche P Alter; Farid Boulad; Carlos Bueso-Ramos; Lauri Burroughs; Paul Castillo; James Connelly; Stella M Davies; Courtney D DiNardo; Iftikhar Hanif; Richard H Ho; Nicole Karras; Michelle Manalang; Lisa J McReynolds; Taizo A Nakano; Grzegorz Nalepa; Maxim Norkin; Matthew J Oberley; Etan Orgel; Yves D Pastore; Joseph Rosenthal; Kelly Walkovich; Jordan Larson; Maggie Malsch; M Tarek Elghetany; Mark D Fleming; Akiko Shimamura Journal: Lancet Haematol Date: 2019-12-23 Impact factor: 18.959
Authors: Noemi A Zambetti; Eric M J Bindels; Paulina M H Van Strien; Marijke G Valkhof; Maria N Adisty; Remco M Hoogenboezem; Mathijs A Sanders; Johanna M Rommens; Ivo P Touw; Marc H G P Raaijmakers Journal: Haematologica Date: 2015-07-16 Impact factor: 9.941
Authors: Kasiani Myers; Kyle Hebert; Joseph Antin; Farid Boulad; Lauri Burroughs; Inga Hofmann; Rammurti Kamble; Margaret L MacMillan; Mary Eapen Journal: Biol Blood Marrow Transplant Date: 2020-05-16 Impact factor: 5.742